New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
10:12 EDTGNC, VSIGNC drops after analyst downgrades on sales concerns
Shares of vitamins and supplements retailer GNC (GNC) are falling after research firm Jefferies downgraded the stock to Hold from Buy in a note to investors today. WHAT'S NEW: The growth of vitamins and supplements sales appear to be slowing, as sales of the products were "flattish" in Q2 and rose only 1% through the four weeks ending July 5, wrote Jefferies analyst Mark Wiltamuth. Until recently, sales of the products had risen at a 6%-10% annual clip for years, the analyst reported. GNC will also face a hit following the FDA's crack down on a pre-workout supplement called DMAA, as the supplement accounted for 8% of the company's sales, Wiltamuth believes. Additionally, the company faces a tough comparison in Q2, as it launched its Gold Card discount plan in the second quarter of 2013, the analyst noted. Warning that GNC's comparative sales could drop in Q2 and Q3, Wiltamuth thinks anemic sales growth could hurt its margins. He slashed his price target on the name to $39 from $50. PRICE ACTION: In early trading, GNC shares fell 82c, or 2.3% to $34.78. One of GNC's competitors, Vitamin Shoppe (VSI), lost 0.7% to $42.72.
News For GNC;VSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 25, 2015
10:01 EDTVSIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:38 EDTVSIVitamin Shoppe downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
February 24, 2015
06:36 EDTVSIVitamin Shoppe sees FY15 EPS $2.36-$2.46, consensus $2.52
Subscribe for More Information
06:36 EDTVSIVitamin Shoppe reports Q4 total comparable sales up 2.1%.
Subscribe for More Information
06:35 EDTVSIVitamin Shoppe reports Q4 adjusted EPS 41c, consensus 41c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use